Skip to Main Content

Seminar Series 2016-2017

February 27, 2017.  Using Synthetic Biology to Bypass Immune Tolerance.” Avery Posey, Jr., Instructor at the Parker Institute for Cancer Immunotherapy, University of Pennsylvania.  Director of a laboratory designing novel cancer immunotherapies, including preclinical designs and evaluations of CAR T cell products, within the Center for Cellular Immunotherapies at the Perelman School of Medicine, University of Pennsylvania.

November 3, 2016.  “Infection and Pubertal Timing Across the Breast Cancer Risk Spectrum.”  Jasmine McDonald, Ph.D., Assistant Professor of Epidemiology at the Mailman School of Public Health (MSPH) and co-Director of the Herbert Irving Comprehensive Cancer Center (HICCC) Continuing Umbrella of Research Experience (CURE) Program, Columbia University, NY, NY.

October 20, 2016. “Harnessing biomaterials to study and engineer immune function.”  Christopher M. Jewell, Ph.D.,  Assistant Professor, Fischell Department of Bioengineering at the University of Maryland, College Park, College Park, MD.

September 28, 2016.  “Novel Gene Discovery in African Americans with Hereditary Focal Segmental Glomerulosclerosis.”  Gentzon Hall, M.D./Ph.D., Medical Instructor in the Department of Medicine and Member of Duke Molecular Physiology Institute, Duke University, Durham, NC.